Autifony Therapeutics Company

Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Technology: AgeTech Companies
Industry: AgeTech, Sensory Aids
Headquarters: London, England, United Kingdom
Founded Date: 2011-01-01
Employees Number: 11-50
Funding Status: N/A
Investors Number: 6
Total Funding: $39,667,750.00
Estimated Revenue: $1M to $10M
Last Funding Date: 2017-03-15
Last Funding Type: Venture - Series Unknown

Visit Website
info@autifony.com
Register and Claim Ownership